PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation
- DOI
- 10.1038/s41375-026-03055-5
- Published
- 2026-07-13
- Container
- Leukemia
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41375-026-03055-5,
title = {PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation},
author = {Yuto Mori and Keito Suto and Norio Takei and Keito Yokoyama and Masahiro Chiba and Takashi Ishio and Hideki Goto and Tomoyuki Endo and Hiroo Hasegawa and Michiyuki Maeda and Satoko Otsuguro and Katsumi Maenaka and Takanori Teshima and Yibin Yang and Masao Nakagawa},
year = {2026},
journal = {Leukemia},
doi = {10.1038/s41375-026-03055-5},
url = {https://doi.org/10.1038/s41375-026-03055-5}
}RIS
TY - JOUR TI - PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation AU - Yuto Mori AU - Keito Suto AU - Norio Takei AU - Keito Yokoyama AU - Masahiro Chiba AU - Takashi Ishio AU - Hideki Goto AU - Tomoyuki Endo AU - Hiroo Hasegawa AU - Michiyuki Maeda AU - Satoko Otsuguro AU - Katsumi Maenaka AU - Takanori Teshima AU - Yibin Yang AU - Masao Nakagawa PY - 2026 JO - Leukemia DO - 10.1038/s41375-026-03055-5 UR - https://doi.org/10.1038/s41375-026-03055-5 ER -
APA
Mori, Y., Suto, K., Takei, N., Yokoyama, K., Chiba, M., Ishio, T., Goto, H., Endo, T., Hasegawa, H., Maeda, M., Otsuguro, S., Maenaka, K., Teshima, T., Yang, Y., & Nakagawa, M. (2026). PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation. Leukemia. https://doi.org/10.1038/s41375-026-03055-5
Source records
- crossref · retrieved 2026-09-27T03:43:42.751Z